scholarly article | Q13442814 |
P50 | author | Riitta Veijola | Q40817090 |
Mikael Knip | Q47161413 | ||
P2093 | author name string | Savolainen H | |
Ilonen J | |||
Simell O | |||
Erkkilä S | |||
Simell T | |||
Korhonen S | |||
Kupila A | |||
Keskinen P | |||
Arvilommi P | |||
P433 | issue | 12 | |
P921 | main subject | type-1 diabetes | Q124407 |
preproinsulin | Q7240673 | ||
P304 | page(s) | 1639-1648 | |
P577 | publication date | 2002-10-30 | |
P1433 | published in | Diabetologia | Q5270140 |
P1476 | title | First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes | |
P478 | volume | 45 |
Q40335643 | Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents |
Q51456535 | Autoantibodies in type 1 diabetes. |
Q37764866 | Autoimmunity and the pathogenesis of type 1 diabetes |
Q89999336 | Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes |
Q50120159 | Class II HLA Genotype Association with First Phase Insulin Response Is Explained by Islet Autoantibodies |
Q73210876 | Current literature in diabetes |
Q28586190 | Deoxyhypusine synthase promotes differentiation and proliferation of T helper type 1 (Th1) cells in autoimmune diabetes |
Q33215130 | Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies |
Q36180400 | Dynamics and Regulation of Insulin Secretion in Pancreatic Islets from Normal Young Children |
Q38895409 | Dysregulation of glucose metabolism in preclinical type 1 diabetes |
Q35857760 | ER stress as a trigger for β-cell dysfunction and autoimmunity in type 1 diabetes |
Q62587873 | Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk |
Q91852554 | Endoplasmic reticulum stress-induced cellular dysfunction and cell death in insulin-producing cells results in diabetes-like phenotypes in Drosophila |
Q33806231 | Environmental factors in the etiology of type 1 diabetes, celiac disease, and narcolepsy |
Q46319669 | Evaluation of glucose homeostasis in transfusion-dependent thalassemic patients |
Q44972607 | Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study |
Q41689680 | Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis |
Q30421540 | Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model |
Q51367940 | Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study. |
Q34468392 | Minireview: 12-Lipoxygenase and Islet β-Cell Dysfunction in Diabetes |
Q62587898 | Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial |
Q37373473 | Natural evolution, prediction, and prevention of type 1 diabetes in youth |
Q33811836 | Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment |
Q36082153 | Predicting type 1 diabetes |
Q35123531 | Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes |
Q36461183 | Reduced β-cell function in early preclinical type 1 diabetes |
Q38692770 | Revisiting multiple models of progression of β-cell loss of function in type 1 diabetes: Significance for prevention and cure |
Q38908327 | Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies |
Q36079915 | The stages of type 1A diabetes: 2005. |
Q36932559 | Translational control of inducible nitric oxide synthase by p38 MAPK in islet β-cells |
Q79184671 | Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives |
Q37830198 | Type 1 diabetes: etiology, immunology, and therapeutic strategies |
Q58792346 | β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis |
Search more.